73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
73%
of retail accounts lose money when trading CFDs with this provider.
Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
73%
of retail investor accounts lose money when trading CFDs with this provider.
You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
English (International)
Establishment Labs Holdings Inc
Closed
SectorHealthcare
65.62 -2.35
Overview
Share price change
24h
Min
65.62
Max
66.51
Income | 5.4M -11M |
|---|---|
Sales | 2.5M 54M |
EPS | -0.38 |
Profit margin | -20.724 |
Employees | 1,023 |
EBITDA | 4.9M -2.1M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +25.73% upside |
Next Earnings | 25 Feb 2026 |
|---|
Market Cap | 577M 2B |
|---|---|
Previous open | 67.97 |
Previous close | 65.62 |
News Sentiment
By Acuity
50%
50%
142 / 352 Healthcare
Technical Score
By Trading Central
Confidence
Very Strong Bullish Evidence
Establishment Labs Holdings Inc Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
Establishment Labs Holdings Inc Forecast
Price Target
By TipRanks
25.73% upside
12 Months Forecast
Average 82.88 USD 25.73%
High 90 USD
Low 75 USD
Based on 8 Wall Street analysts offering 12 month price targets forEstablishment Labs Holdings Inc - Dist in the last 3 months.
Sentiment
By Acuity
142 / 352 Healthcare
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander. The company sells its products to physicians, hospitals, and clinics through distributors and direct sales force in Europe, the Middle East, Latin America, and Asia. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
Live chat